top of page

Innovate, Transform, Grow

Innovative Solutions for Healthcare and Pharma

Marketing

Highlights

+70 years (combined) of drug discovery & development experience

Diverse therapeutics experience

+11 Clinical candidates' Co-inventors

Global research experience

Experienced in in-licensing and out-licensing assets

Who we are?

  • End-to-end drug discovery and development expertise

  • Navigate complexities with precision & speed

  • Decisive leadership with a biotech mindset

  • Agility and expertise to adopt novel technologies

  • Talented multi-disciplinary team with deep functional expertise and knowledge of the Indian, US, and European regulatory landscape and industry standards

  • Hands-on experience working with multiple big pharmaceuticals

  • Proven experience in senior R&D leadership in global organizations

image_edited.png

OUR VISION

Abhinavayan aims to advance global healthcare as a trusted innovation partner, empowering pharmaceutical progress through research, collaboration, and transformative end-to-end solutions.

image_edited.png

OUR MISSION

Our mission is to accelerate innovation and sustainable growth across pharma, biotech, and healthcare by bridging capability gaps and unlocking new therapeutic frontiers through integrated, insight-driven solutions.

image.png

Innovation

We uphold transparency, ethics, and accountability in every decision

image.png

Integrity

We challenge convention to develop transformative, science-driven solutions

image.png

Respect

We foster trust by valuing every partnership, perspective, and contribution

Our important values

image.png

We drive bold science with integrity, respect every voice, and innovate to create lasting impact

image.png
Scientists Collaborating in Laboratory

Our Services

End-to-end Drug Discovery and Development solutions designed to accelerate innovation and drive growth, from bench to market.

Strategic Solutions for Start-ups, CROs, Academic and growing Pharma, empowering progress from discovery through commercialization.

Strategy

Integrated Drug Discovery (End-to-End R&D)

Your trusted R&D partner, delivering high-quality, niche drug discovery & Developments 
  • Innovation Assessment & Acceleration: Evaluate and advance promising scientific breakthroughs, from target identification and validation to hit-to-lead optimization and candidate nomination.

  • Support for Early Innovators: Provide scientific and regulatory guidance to help startups and researchers progress toward the clinic, including IND-enabling studies (toxicology, ADME, and regulatory documentation).

  • Clinical Strategy & Execution: Design and implement clinical strategies with expertise in protocol development, biomarker planning, and site support.

  • Collaborative Partnerships: Work jointly with CROs, academic groups, and early-stage biotechs to co-develop and deliver impactful drug discovery programs.

Consultation Services

Empowering your growth with tailored, high-quality strategic solutions
  • R&D-as-a-Service (RaaS): Offer tailored, preclinical-to-clinical solutions for startups, biotechs, and CROs, with flexible models that adapt to specific scientific needs.

    • End-to-End Program Design: covering discovery to clinical stages

    • Strategic Project Blueprinting: Project roadmaps with clear Go/No-Go checkpoints 

  • Pipeline/Portfolio Optimization: Enhance asset and portfolio value through indication repurposing, therapeutic area expansion and prioritization frameworks for maximum return on investment.

  • Regulatory Strategy: Guide regulatory submissions, compliance, and site preparedness to ensure smooth progression to clinical trials.

  • Partnership and Licensing Support: Assist in structuring and evaluating in-licensing and out-licensing opportunities, while enabling collaborations that accelerate growth and market positioning.

Innovation

Beyond client-focused work, we are advancing our own internal pipeline. These programs reflect our commitment to innovation in oncology and other high-impact areas, where we pursue novel mechanisms and differentiated therapeutic strategies.

Screenshot 2025-07-28 141323.jpg

INSIGHTS

bottom of page